Determinants of Pain, Disability, and QoL in Chronic Inflammatory Demyelinating Polyneuropathy
Pain of any type was a relevant factor for the sequelae of chronic inflammatory demyelinating polyneuropathy.
Pain of any type was a relevant factor for the sequelae of chronic inflammatory demyelinating polyneuropathy.
A secondary analysis sought to identify predictors of pregabalin response in those with chronic posttraumatic neuropathic pain.
A combined unsupervised and supervised machine learning (ML) technique can help predict long-term SCS response for patients with chronic pain.
Don Goldenberg, MD, provides an overview of the various aspects of chronic pain in rheumatology and the inaccurate interchangeability of the terms “fibromyalgia” and “central pain sensitization.” Deeba Minhas, MD, weighs in on addressing the systemic biases in chronic pain.
The aim of the study was to evaluate the prevalence of chronic pain disparities among the major racial and ethnic groups in the US.
This meta-analysis aimed to evaluate the advantages and disadvantages of duloxetine compared with gabapentin for diabetic peripheral neuropathic pain.
Women who were younger at the time of their first menstrual period are more likely to report chronic pain in adulthood.
State laws are associated with small and non-statistically significant changes in opioid prescribing or nonopioid pain treatment.
A mindfulness intervention can lead to greater sustained improvements in opioid misuse and chronic pain symptoms than supportive group psychotherapy.
US overdose deaths involving opioids and stimulant drugs, such as cocaine and methamphetamine, surged between 2009 and 2019, particularly among Black individuals.